Last reviewed · How we verify
Dibasic Calcium Phosphate Dihydrate (calcium hydrogen phosphate dihydrate)
At a glance
| Generic name | calcium hydrogen phosphate dihydrate |
|---|---|
| Therapeutic area | Nephrology |
| Phase | FDA-approved |
Approved indications
- Minor Muscle Cramps
- Menstrual Cramps
- General Bone and Joint Health
- Support Normal Growth
- Minor Tooth Pain
- Teething
Common side effects
- Electrolyte imbalance
- Acid-base disorders
- Metabolic acidosis
- Hypotension
- Fluid imbalance
- Hyperphosphatemia
- Hypophosphatemia
- Calcium ionized increased
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Dibasic Calcium Phosphate Dihydrate CI brief — competitive landscape report
- Dibasic Calcium Phosphate Dihydrate updates RSS · CI watch RSS
- portfolio CI